Primary record
Fluorouracil Imp. C (EP); Lamivudine Imp. F (EP); Pyrimidine-2,4(1H,3H)-dione; Uracil; 144U51; Lamivudine related; Nelarabine related; Uracil (144U51); (AH 9617); Cytarabine Impurity D; Fluorouracil Impurity C; Lamivudine Impurity F
- 库存
- 2,419 克
- 纯度
- 99.6 %
- CAS
- 66-22-8
化合物标识与属性
- CAS
- 66-22-8
- PubChem CID
- 1174
- SMILES
- C1=CNC(=O)NC1=O
- Canonical SMILES
- O=c1cc[nH]c(=O)[nH]1
名称与同义词
- uracil
- 2,4-Dihydroxypyrimidine
- Pyrod
- pyrimidine-2,4-diol
- Pirod
- Hybar X
- 66-22-8
- 2,4-Pyrimidinediol
- 2,4(1H,3H)-Pyrimidinedione
- pyrimidine-2,4(1H,3H)-dione
- 2,4-Dioxopyrimidine
- 2,4-Pyrimidinedione
- 1H-Pyrimidine-2,4-dione
- 4-Hydroxyuracil
- pyrimidinedione
- Uracil [USAN]
- Uracilo
- Uracyl
- Urazil
- Xyfid
- Uracil topical
- Unknown Ligand
- 2-Pyrimidinol
- 8h-uracil
- hydroxypyrimidinone
- Lamivudine impurity e
- Uracil (8CI)
- Uracil (Standard)
- 24-Dioxopyrimidine
- Uracil-5-d
- 2,4-pirimidinediol
- C4H4N2O2
- 2 4-Pyrimidinediol
- 2,6-Dioxypyrimidin
- Uracil [USAN:JAN]
- 2,4-pirimidinediona
- 2 4-Pyrimidinedione
- 2,4-Dioxopirimidine
- 2,4-Dioxypyrimidine
- 1,2,3,4-tetrahydropyrimidine-2,4-dione
- 2,4-Pyrimidinediol (9CI)
- Cytarabine Impurity D
- Lamivudine impurity e rs
- Uracil-5-3H
- 2-Hydroxy-4(3H)-pyrimidinone
- pyrimidine-2,4-dione
- 24-Dihydroxypyrimidine
- 2, 4-Dioxopyrimidine
- 51953-14-1
- 56HH86ZVCT
- Pazopanib Impurity 22
- RefChem:6338
- CCRIS 3077
- Fluorouracil Impurity C
- MFCD00006016
- Uracil =99%
- Uracil, 99%
- uridine-5'-diphosphate
- 1ui0
- Uracil (JAN/USAN)
- 2-Hydroxy-4(1H)-pyrimidinone
- 2,3H)-Pyrimidinedione
- UNII-56HH86ZVCT
- URACIL 1KG
- 2,4-Dihidroxipirimidine
- 2,6-Dihydroxypyrimidine
- 4(6)-Hydroxypyrimidine
- DTXSID4021424
- URACIL-1,3-D2
- CHEBI:17568
- URACIL-6-D1
- URACIL-D4
- 2-oxy-4-oxy pyrimidine
- AC1Q6GOT
- NSC 3970
- NSC-3970
- URACIL [JAN]
- URACIL [USP-RS]
- URACIL [WHO-DD]
- Uracil, 99% 50g
- Lamivudine EP Impurity F
- URACIL [MI]
- 4-Hydroxy-2(1H)-pyrimidinone
- ISAKRJDGNUQOIC-UHFFFAOYSA-N
- URACIL [MART.]
- ACMC-1AS5O
- ACMC-1C4TI
- URACIL 50G
- Uracil C-13, 2-
- RU 12709
- bmse000187
- bmse000940
- CHEMBL566
- D0Y0DG
- Epitope ID:120356
- URACIL-5,6-D2
- Fluorouracil EP Impurity C
- NCIMech_000782
- AC1L1AW5
- AC1Q1GU8
- NSC3970
- SCHEMBL8235
- URACIL 250G
- URACIL-5-D1
- DTXCID101424
- Fluorouracil impurity C CRS
- Uracil, >=99.0%
- SQ 6201
- SQ 7726
- SQ 8493
- SQ-6201
- SQ-7726
- SQ-8493
- 2(1H)-Pyrimidinone, 4-hydroxy-
- 2(1H)-Pyrimidinone, 6-hydroxy-
- 4(3H)-Pyrimidinone, 2-hydroxy-
- pyrimidine, 2,4-dihydroxy-
- SCHEMBL29730
- SCHEMBL80962
- SCHEMBL94310
- 2 -Pyrimidinone,6-hydroxy-
- 4 -Pyrimidinone,2-hydroxy-
- Fluorouracil specified compound c
- KSC352S4R
- MLS001304993
- SCHEMBL144010
- SCHEMBL151239
- SCHEMBL537174
- SCHEMBL877869
- SCHEMBL925137
- EINECS 200-621-9
- BMS 205603-01
- BMS-205603-01
- AI3-25470
- GTPL4560
- orb1310972
- SCHEMBL1050479
- SCHEMBL5089507
- SCHEMBL6286831
- SCHEMBL6434097
- SCHEMBL6434098
- SCHEMBL7267501
- SCHEMBL7335265
- SCHEMBL9734266
- SCHEMBL9779787
- 2,4(1h, 3h)-pyrimidinedione
- 2,4-(1h,3h)-pyrimidinedione
- 4-Hydroxy-2(3H)-pyrimidinone
- Pyrimidine-2,4-diol / Uracil
- 2-hydroxy-4-(1H)-pyrimidione
- 2-hydroxy-4-(3H)-pyrimidione
- 2-Hydroxypyrimidine-4(1H)-one
- 4-hydroxy-2-(1H)-pyrimidione
- 4-Hydroxypyrimidine-2(3H)-one
- SCHEMBL10580164
- SCHEMBL11607890
- SCHEMBL13276278
- SCHEMBL29525634
- SCHEMBL31434533
- URACIL (REFERENCE GRADE)
- URACIL, [2-14C]
- CTK1G3699
- CTK1G8296
- CTK1I0613
- CTK1J5004
- CTK2F2948
- HY-I0960R
- CID1174
- Uracil, >=99.0% (T)
- 1,3-dihydropyrimidine-2,4-dione
- 2,4 (1h, 3h)-pirimidinaediona
- HMS2234E19
- HMS3264C13
- HMS3373E18
- HMS3652N05
- HMS5082D06
- Pharmakon1600-01502345
- ZINC895045
- 4(1H)-Pyrimidinone, 2-hydroxy-
- Uracil 99% for biochemistry 25gm
- 2,4(1H,3H)-Pyrimidinedione (9CI)
- BCP26546
- C4-H4-N2-O2
- CID:1174
- HY-I0960
- NSC29742
- ZAA89752
- Tox21_112680
- Tox21_201023
- ANW-31373
- ANW-35165
- AR-1L7967
- BDBM50549809
- CCG-35866
- EBC-13197
- MSK000882
- NCGC00181030-01
- NP0505
- NSC-29742
- NSC759649
- s4177
- SBB058492
- STK301734
- STL124066
- 4(1H)-Pyrimidinone, 2-hydroxy- (9CI)
- 4(3H)-Pyrimidinone, 2-hydroxy- (9CI)
- AKOS000119989
- AKOS002303991
- Tox21_112680_1
- Uracil, 98% - 100G 100g
- 3-Bromo-2,6-diiodo-5-methoxypyridine
- 4(3H)-Pyrimidinone,2-hydroxy-(9ci)
- ACN-028655
- AM83913
- CCG-213042
- CS-T-46139
- CS-W020104
- DB03419
- FU01843
- J4.842I
- LS-7748
- NSC-759649
- PS-5279
- RP18951
- SB55489
- SB55884
- 4-Hydroxy-1,2-dihydropyrimidine-2-one
- CAS-66-22-8
- CID 5274267
- KS-0000024N
- Ura
- 5,6-ditritio-1H-pyrimidine-2,4-dione
- ethyl 2-oxo-3-(pyridin-4-yl)propanoate
- NCGC00181030-02
- NCGC00247663-01
- NCGC00258576-01
- Uracil, Vetec(TM) reagent grade, 98%
- 4CN-0756
- AJ-24138
- AK-86824
- AN-23751
- CJ-04447
- NCI60_003718
- Pyrimidine-2,4(1H,3H)-dione (Uracil)
- RU-12709
- SC-09054
- SC-29470
- SID:76715622
- SMR000752912
- SY008943
- TL806199
- ZB014964
- 2(1H)-Pyrimidinone, 6-hydroxy- (9CI)
- AB0008404
- DB-030518
- DB-103964
- DB-268940
- DB-268966
- DB-272084
- DB-272202
- LAMIVUDINE IMPURITY F [EP IMPURITY]
- TC-120118
- B1863
- BB 0242167
- FLUOROURACIL IMPURITY C [EP IMPURITY]
- FT-0609769
- FT-0694063
- FT-0695907
- FT-0695908
- FT-0773727
- FT-0776959
- LAMIVUDINE IMPURITY E [USP IMPURITY]
- NS00002070
- ST45061548
- SW220239-1
- U0013
- 66255-05-8
- EN300-17138
- Uracil, suitable for cell culture, BioReagent
- 4177-EP2270010A1
- 4177-EP2270015A1
- 4177-EP2272832A1
- 4177-EP2275420A1
- 4177-EP2281563A1
- 4177-EP2287152A2
- 4177-EP2292593A2
- 4177-EP2295055A2
- 4177-EP2295408A1
- 4177-EP2295414A1
- 4177-EP2295416A2
- 4177-EP2295434A2
- 4177-EP2295441A2
- 4177-EP2295503A1
- 4177-EP2298748A2
- 4177-EP2298764A1
- 4177-EP2298765A1
- 4177-EP2298778A1
- 4177-EP2298783A1
- 4177-EP2303848A2
- 4177-EP2305219A1
- 4177-EP2305642A2
- 4177-EP2305684A1
- 4177-EP2305808A1
- 4177-EP2305825A1
- 4177-EP2311453A1
- 4177-EP2311815A1
- 4177-EP2311842A2
- 4177-EP2316459A1
- C00106
- D00027
- M-6157
- SBI-0053640.0002
- X-2151
- 2-oxo-3-pyridin-4-yl-propionic acid ethyl ester
- AB00171810_03
- AB00171810_04
- AB00918623-05
- 142257-EP2272848A1
- 142257-EP2292593A2
- A835376
- AC-907/30002021
- D014498
- F036407
- Q182990
- 144104-68-7
- 4'-C-Azido-2'-deoxy-2'-fluoro-b-D-arabinouridine
- 51953-20-9
- 66224-60-0
- I03-0056
- BRD-K80129304-001-08-1
- BRD-K80129304-001-09-9
- Z56889474
- F1796-0008
- FLUOROURACIL SPECIFIED COMPOUND C [USP IMPURITY]
- E2FC11E5-1887-46DF-B415-82313CE9B2BD
- Uracil, United States Pharmacopeia (USP) Reference Standard
- 1,4-Oxaphosphorinanium,2,2,6-trimethyl-4,4-diphenyl-,bromide
- 20666-60-8
- 51953-19-6
- Uracil; Lamivudine EP Impurity F; Fluorouracil EP Impurity C
- 103204-67-7
- 2,4(1H,3H)-Pyrimidinedione; 2,4-Dihydroxypyrimidine; 2,4-Pyrimidinediol
- 24897-50-5
- 24897-51-6
- 24897-52-7
- 766-19-8
- Fluorouracil impurity C, European Pharmacopoeia (EP) Reference Standard
- InChI=1/C4H4N2O2/c7-3-1-2-5-4(8)6-3/h1-2H,(H2,5,6,7,8
- Uracil, Pharmaceutical Secondary Standard; Certified Reference Material
- 15018-56-1
- 173379-73-2
- 200-621-9
- 24897-55-0
- 35803-45-3
- 35978-19-9
- 4214-76-0
- 6165-71-5
- 626-07-3
- 8077-38-1
- Fluorouracil Imp. C (EP); Lamivudine Imp. F (EP); Pyrimidine-2,4(1H,3H)-dione; Uracil; 144U51; Lamivudine related; Nelarabine related; Uracil (144U51); (AH 9617); Cytarabine Impurity D; Fluorouracil Impurity C; Lamivudine Impurity F
- UDP
- UNL